Retatrutide (also known as LY-3437943) is an experimental medication developed by Eli Lilly that is being studied as a next-generation treatment for obesity, overweight, and related metabolic conditions such as type 2 diabetes
Factores como la edad, el metabolismo, la tolerancia y el estado general de salud influyen en la respuesta del organismo
Set reminders if you do not feel thirst naturally
These platforms connect you with licensed professionals who can prescribe personalized, science-based treatments
A 2025 letter in Diabetes Care acknowledged that microdosing could play a role in optimizing therapy around challenges like availability, affordability, and tolerability
Environ Exp Bot 61:8593 Tamaoki M, Matsuyama T, Nakajima N, Aono M, Kubo A, Saji H (2004) A method for diagnosis of plant environmental stresses by gene expression profiling using a cDNA macroarray